SCNI
$0.70
Post-MarketAs of Mar 17, 8:00 PM UTC
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
Recent News
No recent news found.